Last mentioned: Mar 16, 2026
Enforcement Begins
Medicare payments will be withheld from off-campus HOPDs that lack a unique NPI and valid attestation.
Initial Filing Deadline
Final day for hospitals to submit initial attestations for all existing off-campus departments.
Initial Expiration
The first six-month period ends, pending potential CMS extension.
Initial Expiration
CMS will evaluate whether to lift the moratorium or extend it for another six months.
Initial Expiration
The first six-month period ends, at which point CMS may choose to extend the moratorium.
Van Nuys Discovery
Investigative reports highlight 89 licenses at a single Van Nuys address, sparking national outcry.
Earnings Call
Management confirms CMS reimbursement rate of $897 and 2025 assay expansion.
Q4 2025 Earnings
Company reports 25% total revenue growth and progress in clinical diagnostic pivot.
Moratorium Effective Date
Nationwide freeze on new DMEPOS enrollments officially begins.
Moratorium Effective Date
Nationwide freeze on new DMEPOS enrollments officially begins.
Moratorium Effective
CMS officially publishes the notice and the nationwide enrollment freeze begins immediately.
Legislation Enacted
President signs the Consolidated Appropriations Act of 2026 into law.
FDA Submission
510(k) premarket notification submitted for Lucent AD Complete.
FDA 510(k) Submission
Premarket notification submitted for Lucent AD Complete diagnostic test.
CMS Rulemaking
CMS expected to establish the formal process and portal for NPI and attestation submissions.
Q4 2025 Close
Quanterix reports $43.9M in revenue with 25% YoY growth.
CMS Reimbursement Milestone
CMS approves $897 reimbursement rate for Lucent AD Complete, establishing a national reference price.
Data Review Period Ends
CMS concludes a multi-year review of high-risk enrollment and claims data.
Data Review Period Ends
CMS concludes a review showing a 17% spike in DMEPOS enrollment and claims activity.
Data Review Concludes
CMS finishes a multi-year review of Medicare enrollment and claims data identifying high-risk trends.
Federal and state regulators are intensifying scrutiny of California's hospice industry after discovering a single Van Nuys office building housing 89 separate hospice licenses. This discovery highlights systemic vulnerabilities in Medicare oversight and has triggered a broader national push for legislative reform.
HHS Assistant Secretary Brian Christine has announced that detransition care will be a primary focus for the department, signaling a pivot in federal healthcare policy. This move is expected to trigger significant regulatory updates and legal scrutiny regarding the standards of care for gender-related medical services.
The Centers for Medicare & Medicaid Services (CMS) has implemented a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. This aggressive regulatory move, effective February 27, 2026, aims to curb systemic fraud and billions in improper payments within the DMEPOS sector.
The Centers for Medicare & Medicaid Services has implemented a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. Effective February 27, 2026, this aggressive regulatory action aims to curb systemic fraud and improper payments within the DMEPOS sector.
The Centers for Medicare & Medicaid Services (CMS) has enacted a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. This aggressive regulatory action, effective February 27, 2026, aims to curb systemic fraud and improper billing within the DMEPOS sector.
Minnesota has filed a federal lawsuit against the Trump administration, alleging the illegal use of Medicaid funding as a political tool to coerce state policy. The legal challenge argues that the executive branch is violating the Spending Clause and the Administrative Procedure Act by withholding essential healthcare dollars.
Quanterix reported Q4 2025 revenue of $43.9 million, driven by a 25% year-over-year increase and significant progress in its Alzheimer’s diagnostic portfolio. Despite organic declines in its core Simoa and Spatial segments, the company secured a $897 CMS reimbursement rate for its Lucent AD Complete test and submitted its 510(k) to the FDA.
Quanterix reported a 25% year-over-year revenue increase to $43.9 million in Q4 2025, driven by a surge in diagnostics partner revenue and critical regulatory milestones. The company achieved a commercial breakthrough with a $897 CMS reimbursement rate for its Lucent AD Complete test, positioning it for large-scale clinical adoption.
The Trump administration has moved to withhold federal Medicaid funding from Minnesota, triggering a wave of condemnation from healthcare advocates and state officials. The funding freeze threatens the state's healthcare safety net and marks a significant escalation in federal-state regulatory friction over program administration.
The Consolidated Appropriations Act of 2026 mandates that all off-campus hospital outpatient departments (HOPDs) obtain unique National Provider Identifiers and submit formal provider-based attestations. This regulatory shift ends the long-standing voluntary compliance system and sets a hard enforcement deadline of January 1, 2028.
Vice President JD Vance announced a suspension of federal Medicaid payments to Minnesota, citing significant concerns regarding fraudulent activity and oversight failures. The move represents a major escalation in federal-state tensions over healthcare program integrity.